Table 3. The associations between genetic polymorphisms and clinical characteristics of T2D.

SNP	genotype	n	HbA1c		TG		Cr		Cys-c		BMI
			mean ± SD	p*	mean ± SD	p*	mean ± SD	p*	mean ± SD	p*	mean ± SD	p*
rs2811893(MYSM1)	TT	130	9.56±2.81	0.083	2.53±2.20	0.906	71.18±38.63	0.006*	0.87±0.26	0.975	24.79±3.59	0.495
	CT	148	9.15±1.98		2.51±2.19		61.95±18.39		0.87±0.56		24.90±3.36
	CC	40	8.68±1.66		2.68±2.37		11.93±1.89		0.86±0.17		25.52±3.24
rs13064954(Unknown)	AA	4	10.95±2.03	0.343	7.59±5.17	0.001*	66.47±21.70	0.584	0.85±0.20	0.615	25.27±3.94	0.555
	GG	257	9.22±2.40		2.53±2.20		64.67±27.78		0.85±0.23		24.82±3.52
	AG	58	9.25±1.99		2.22±1.51		68.94±31.10		0.97±0.84		25.35±3.06
rs17376456(KIAA0825)	AA	280	9.35±2.38	0.039*	2.56±2.91	0.6	65.56±29.67	0.88	0.87±0.44	0.526	24.92±3.49	0.884
	GA	39	8.53±1.78		2.36±1.49		64.83±15.70		0.83±0.20		25.00±3.44
rs7772697(Unknown)	TT	223	9.18±2.40	0.455	2.61±2.38	0.584	65.88±29.90	0.916	0.88±0.48	0.779	25.25±3.48	0.028*
	CT	85	9.51±2.26		2.39±1.83		64.48±25.11		0.85±0.19		24.09±3.34
	CC	11	8.85±1.23		2.08±0.90		63.29±18.46		0.83±0.30		24.69±2.28
rs3918227(NOS3)	CA	49	8.96±1.74	0.338	2.00±1.07	0.117	63.85±18.03	0.664	1.02±0.91	0.045*	25.09±3.53	0.075
	CC	270	9.31±2.42		2.63±2.35		65.76±29.82		0.84±0.23		24.89±3.43
rs4838605(ARHGAP22)	TT	243	9.34±2.43	0.216	2.66±2.36	0.041*	65.77±23.91	0.737	0.89±0.46	0.168	24.95±3.28	0.777
	TC	76	8.97±1.97		2.13±1.56		64.51±39.42		0.81±0.25		24.82±3.92
rs6214(IGF1)	TT	72	10.10±3.34	0.006*	2.51±2.36	0.155	61.03±15.20	0.319	0.85±0.27	0.571	25.10±3.43	0.803
	CC	105	8.98±1.86		2.22±1.60		66.57±26.55		0.90±0.63		24.76±3.51
	TC	142	9.03±1.91		2.78±2.48		66.90±34.05		0.85±0.26		24.96±3.41

HbA1C = glycosylated hemoglobin A1c; TG = triglyceride; Cr = creatinine; Cys-c = cystatin C; BMI= body mass index;

OR = odds ratio; 95%CI = 95 % confidence interval;

*p ≤ 0.05 indicates statistical significance.